Postoperative and Adjuvant Intravesical Therapy of Superficial Bladder Tumours

BACKGROUND: The aim of this questionnaire was to obtain an impression of the practice and applied therapeutic agents in postoperative and -adjuvant intravesical therapy of superficial bladder tumours. PATIENTS AND METHODS: Standardised question-naires answered by urologists about instillation therapy in 351 patients were analysed. RESULTS: Results showed a discrepancy between the clinical practice and the guidelines in respect of the postoperative instillations and the use of BCG immunotherapy, respectively. CONCLUSION: It does not seem to be standard practice to treat every patient with one immediate post-operative instillation. Only a minority of high-risk patients received intravesical BCG instillations. Substances mainly used for instillation therapy were mitomycin C and doxorubicin.